Calcimimetics for predialysis patients? [3] (multiple letters)

American Journal of Kidney Diseases

Volumn 47, Issue 1, 2006, Pages 196-197

  Fournier, Albert ^a   Shahapuni, Irina ^a   Harbouche, Laïd ^a   Monge, Matthieu ^a   Charytan, Chaim ^b  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMIMETIC AGENT; CALCIUM; CALCIUM SENSING RECEPTOR; CINACALCET; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATE BINDING AGENT; PLACEBO; VITAMIN D;

BONE METABOLISM; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG USE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYPERPHOSPHATEMIA; HYPOCALCEMIA; KIDNEY TUBULE ABSORPTION; LETTER; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRACTICE GUIDELINE; PREVALENCE; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

CALCIFEDIOL; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPOCALCEMIA; KIDNEY DISEASES; NAPHTHALENES; PARATHYROID HORMONE; PHOSPHATES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 29244462017     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.09.036     Document Type: Letter

References (0)